Results 211 to 220 of about 165,244 (251)
Some of the next articles are maybe not open access.
Journal of the American Academy of Nurse Practitioners, 1992
The reported change in the incidence of systemic lupus erythematosus (SLE) is mainly due to a greater awareness of the disease, and to the introduction of serological detection methods such as the LE cell assay and subsequently a variety of other antinuclear antibody assays.
A J, Swaak, J C, Nossent, R J, Smeenk
openaire +4 more sources
The reported change in the incidence of systemic lupus erythematosus (SLE) is mainly due to a greater awareness of the disease, and to the introduction of serological detection methods such as the LE cell assay and subsequently a variety of other antinuclear antibody assays.
A J, Swaak, J C, Nossent, R J, Smeenk
openaire +4 more sources
The Journal of the American Dental Association, 1980
A case of osteomyelitis of the mandible in a patient with systemic lupus erythematosus is described. Both the disease process and the treatment modalities must be understood for correct management.
S J, Samuelson +2 more
openaire +2 more sources
A case of osteomyelitis of the mandible in a patient with systemic lupus erythematosus is described. Both the disease process and the treatment modalities must be understood for correct management.
S J, Samuelson +2 more
openaire +2 more sources
Baillière's Clinical Rheumatology, 1993
Systemic lupus erythematosus (SLE) is the most common of the connective tissue disorders and can involve virtually any organ in the body. It is associated with pleuropulmonary manifestations in well over 50% of cases. Pleuritis with or without pleural effusion is the most common manifestation and can be particularly troublesome to manage but is rarely ...
D, Mulherin, B, Bresnihan
openaire +2 more sources
Systemic lupus erythematosus (SLE) is the most common of the connective tissue disorders and can involve virtually any organ in the body. It is associated with pleuropulmonary manifestations in well over 50% of cases. Pleuritis with or without pleural effusion is the most common manifestation and can be particularly troublesome to manage but is rarely ...
D, Mulherin, B, Bresnihan
openaire +2 more sources
Annals of Internal Medicine, 2013
Systemic lupus erythematosus (lupus) is characterized by aberrant activity of the immune system, leading to variable clinical symptoms. Lupus is more prevalent in African American women and women in other ethnic minority groups. Diagnosing, treating, and identifying novel therapies for lupus is challenging because of its genetic and phenotypic ...
Marianthi, Kiriakidou +3 more
openaire +2 more sources
Systemic lupus erythematosus (lupus) is characterized by aberrant activity of the immune system, leading to variable clinical symptoms. Lupus is more prevalent in African American women and women in other ethnic minority groups. Diagnosing, treating, and identifying novel therapies for lupus is challenging because of its genetic and phenotypic ...
Marianthi, Kiriakidou +3 more
openaire +2 more sources
Medical Clinics of North America, 1986
Systemic lupus erythematosus is a multisystem inflammatory disease characterized by autoantibody production. Recent investigations are providing insights into the immunoregulatory disturbances underlying this disease, and are clarifying the approach to diagnosis and treatment.
openaire +3 more sources
Systemic lupus erythematosus is a multisystem inflammatory disease characterized by autoantibody production. Recent investigations are providing insights into the immunoregulatory disturbances underlying this disease, and are clarifying the approach to diagnosis and treatment.
openaire +3 more sources
Best Practice & Research Clinical Rheumatology, 2022
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that leads to multiple organ damage. For over half a century, SLE has been treated mainly with nonspecific glucocorticoids and immunosuppressants, and the development of molecular target drugs with few adverse reactions is awaited.
openaire +2 more sources
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that leads to multiple organ damage. For over half a century, SLE has been treated mainly with nonspecific glucocorticoids and immunosuppressants, and the development of molecular target drugs with few adverse reactions is awaited.
openaire +2 more sources
Drugs of Today, 2002
Systemic lupus erythematosus is a pleomorphic, autoimmune disorder of unknown cause that can afflict all parts of the body. New insights into its pathogenesis, the employment of preventive measures and combinations of immunosuppressive therapy, as well as the introduction of biologics, are beginning to alter the prognosis and improve the quality of ...
openaire +2 more sources
Systemic lupus erythematosus is a pleomorphic, autoimmune disorder of unknown cause that can afflict all parts of the body. New insights into its pathogenesis, the employment of preventive measures and combinations of immunosuppressive therapy, as well as the introduction of biologics, are beginning to alter the prognosis and improve the quality of ...
openaire +2 more sources
Systemic Lupus Erythematosus and Discoid Lupus Erythematosus
Oral and Maxillofacial Surgery Clinics of North America, 2008The management of a patient with SLE presents the OMS with a challenging array of decisions to make in regards to treatment sequencing. Careful reviews of the patient's medical history, the presentation of the illness, and the medication profile, and an open discourse with medical colleagues are necessary to ensure the safety of patients.
openaire +2 more sources
Clinical and Experimental Dialysis and Apheresis, 1981
(1981). Systemic Lupus Erythematosus. Clinical and Experimental Dialysis and Apheresis: Vol. 5, No. 1-2, pp. 93-99.
openaire +2 more sources
(1981). Systemic Lupus Erythematosus. Clinical and Experimental Dialysis and Apheresis: Vol. 5, No. 1-2, pp. 93-99.
openaire +2 more sources